LobbyingPillnurse lobbying by quarter
Pillnurse's latest lobbying report covers Q1 2020, at under $5,000. Its first report covers Q2 2019; the issues it reports most are Alcohol & Drug Abuse and Health Issues.
Pillnurse
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2019
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2019 | $0 | 1 |
| Q3 2019 | $0 | 1 |
| Q4 2019 | $0 | 1 |
| Q1 2020 | $0 | 1 |
| Q2 2020 | $0 | 0 |
| Q3 2020 | $0 | 0 |
| Q4 2020 | $0 | 0 |
| Q1 2021 | $0 | 0 |
| Q2 2021 | $0 | 0 |
| Q3 2021 | $0 | 0 |
| Q4 2021 | $0 | 0 |
| Q1 2022 | $0 | 0 |
| Q2 2022 | $0 | 0 |
| Q3 2022 | $0 | 0 |
| Q4 2022 | $0 | 0 |
| Q1 2023 | $0 | 0 |
| Q2 2023 | $0 | 0 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Alcohol and drug abuse$0 · 4 reports
- Health issues$0 · 4 reports
- Medical research and clinical labs$0 · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
- SENATE4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Iseman & Associates | $0 | 4 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/09/03for Q1 2020 | Iseman & Associates | Under $5,000 |
| 25/09/03for Q4 2019 | Iseman & Associates | Under $5,000 |
| 25/09/03for Q3 2019 | Iseman & Associates | Under $5,000 |
| 25/09/03for Q2 2019 | Iseman & Associates | Under $5,000 |
| 25/09/02for Q1 2020 | Iseman & Associates | $22.5K |
| 25/09/02for Q4 2019 | Iseman & Associates | $10K |
| 25/09/02for Q3 2019 | Iseman & Associates | $10K |
| 25/09/02for Q2 2019 | Iseman & Associates | $10K |
| 25/08/21for Q4 2019 | Iseman & Associates | $10K |
| 25/08/21for Q3 2019 | Iseman & Associates | $10K |
| 25/08/21for Q2 2019 | Iseman & Associates | $10K |
| 25/08/20for Q4 2019 | Iseman & Associates | $10K |
| 25/08/20for Q3 2019 | Iseman & Associates | $10K |
| 25/08/20for Q2 2019 | Iseman & Associates | $10K |
| 25/05/09for Q4 2019 | Iseman & Associates | $7,500 |
| 25/05/09for Q3 2019 | Iseman & Associates | $7,500 |
| 25/05/09for Q2 2019 | Iseman & Associates | $7,500 |